Condition:   Lung Neoplasms
Interventions:   Drug: DOCETAXEL;   Radiation: Intensity Modulated Radiotherapy (IMRT);   Drug: CISPLATIN
Sponsors:   Sanofi;   Sanofi
Active, not recruiting – verified October 2013

View full post on ClinicalTrials.gov: “Lung Neoplasms” | updated in the last 30 days

{ 0 comments }


thejournal.ie
Simple Blood Test Can Diagnose Lung, Other Cancers
Science Daily (press release)
Oct. 15, 2013 — Early-stage lung and prostate cancers as well as their recurrence can be detected with a simple blood test, according to a study presented at the ANESTHESIOLOGY™ 2013 annual meeting. Serum-free fatty acids and their metabolites may be 
Screening for biomarkers could help determine success of tumor-removal Newswise (press release)
New blood test can diagnose lung, prostate cancerBusiness Standard

all 5 news articles »

View full post on lung cancer – Google News

{ 0 comments }

Concurrent Chemoradiotherapy Using Intensity Modulated Radiotherapy (IMRT) & Docetaxel-cisplatin (or Carboplatin) Followed by Adjuvant Chemotherapy for Inoperable Stage III Non-small-cell Lung Cancer

October 16, 2013

Condition:   Lung NeoplasmsInterventions:   Drug: DOCETAXEL;   Radiation: Intensity Modulated Radiotherapy (IMRT);   Drug: CISPLATINSponsors:   Sanofi;   SanofiActive, not recruiting – verified October 2013 View full post on ClinicalTrials.gov: “Lung Neoplasms” | updated in the last 30 days //

Read the full article →

Trovagene launches pharmaceutical alliance to monitor lung cancer patients … – News-Medical.net

October 16, 2013

Trovagene launches pharmaceutical alliance to monitor lung cancer patients …News-Medical.netLung cancer is the most prevalent cancer in the United States, with more than 225,000 new cases diagnosed annually. EGFR mutations are present in 10 to 35 percent of lung cancers, and these mutations frequently occur during the course of therapy, …and more » View full post on [...]

Read the full article →

Evaluation of the High Dose of Icotinib in Advanced Lung Cancer Patients After Failure of Target Therapy

October 16, 2013

Condition:   NSCLCIntervention:   Drug: IcotinibSponsors:   Anhui Medical University;   Anhui Medical UniversityNot yet recruiting – verified October 2013 View full post on ClinicalTrials.gov: “Lung Neoplasms” | updated in the last 30 days //

Read the full article →

Phase I Study of Tetrathiomolybdate in Combination With Carboplatin/Pemetrexed in Metastatic Non-squamous Non-small Cell Lung Cancer

October 16, 2013

Condition:   Non-Squamous Non-Small Cell Lung CancerIntervention:   Drug: TetrathiomolybdateSponsors:   University of Rochester;   University of RochesterNot yet recruiting – verified October 2013 View full post on ClinicalTrials.gov: “Lung Neoplasms” | updated in the last 30 days //

Read the full article →

Open-label Study of Bevacizumab (AVASTIN®) in Combination With Platinum-containing Chemotherapy as First-line Treatment of Patients With Advanced or Recurrent Non-squamous Non-small Cell Lung Cancer

October 16, 2013

Conditions:   Non-small Cell Lung Cancer;   UnresectableIntervention:   Sponsors:   University of Athens;   University of AthensRecruiting – verified October 2013 View full post on ClinicalTrials.gov: “Lung Neoplasms” | updated in the last 30 days //

Read the full article →

Blood test can differentiate between benign lung nodules and early stage lung … – Medical Xpress

October 16, 2013

NEWS.com.au Blood test can differentiate between benign lung nodules and early stage lung …Medical Xpress"These studies suggest that Indi's technology is capable of detecting the molecular signature of lung cancer by measuring the presence of multiple proteins in a patient's blood," said Paul Kearney, Ph.D., president and chief science officer, Indi and …Blood test may [...]

Read the full article →

Blood test can differentiate between benign lung nodules and early stage lung … – Medical Xpress

October 16, 2013

NEWS.com.au Blood test can differentiate between benign lung nodules and early stage lung …Medical Xpress"These studies suggest that Indi's technology is capable of detecting the molecular signature of lung cancer by measuring the presence of multiple proteins in a patient's blood," said Paul Kearney, Ph.D., president and chief science officer, Indi and …Blood test may [...]

Read the full article →

The Roles of Age, Comorbidity, and Telomere Length in Lung Cancer Treatment and Progonosis

October 16, 2013

Condition:   Lung CancerIntervention:   Sponsors:   National Taiwan University Hospital;   National Taiwan University HospitalRecruiting – verified October 2013 View full post on ClinicalTrials.gov: “Lung Neoplasms” | updated in the last 30 days //

Read the full article →